Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Mozart Relapse Study [Phase 3]
Phase 3 clinical trial update for Mozart Relapse Study in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs [Phase 3]
Phase 3 trial comparing ziprasidone to clozapine for schizophrenia patients who do not respond or tolerate other antipsychotics; study compl…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients [Phase 3]
Phase 3 trial comparing ziprasidone to other atypical antipsychotics in schizophrenia and schizoaffective disorder completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) [Phase 3]
Phase 3 clinical trial update for intramuscular and oral therapy in acute exacerbation of schizophrenia (BIZET Study) conducted by Pfizer/My…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial update on the efficacy and safety of ziprasidone for acute exacerbation of schizophrenia or schizoaffective disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. [Phase 4]
A Phase 4 trial comparing ziprasidone to olanzapine in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 trial of ziprasidone in acute exacerbation of schizophrenia or schizoaffective disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis [Phase 4]
Phase 4 trial updating the efficacy and safety of intramuscular ziprasidone followed by oral ziprasidone for psychosis in schizophrenia/mani…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs [Phase 4]
Phase 4 clinical trial updating on the effects of ziprasidone for schizophrenia or schizoaffective disorder in patients switched from other …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders [Phase 2]
Phase 2 trial update evaluating the safety and tolerability of oral ziprasidone in children and adolescents with psychotic disorders complet…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients [Phase 4]
Phase 4 trial comparing ziprasidone to aripiprazole in hospitalized schizophrenia or schizoaffective disorder patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients [Phase 4]
Phase 4 open-label, non-comparative switch study of ziprazidone in previously treated schizophrenia patients was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder [Phase 4]
A Phase 4 clinical trial evaluated the effects of cross-titrating antipsychotics with ziprasidone in schizophrenia or schizoaffective disord…
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Clozapine from Accord Healthcare Inc., resulting in labeling changes for the drug.
-
FDA approval · 2021-02-18FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2021-02-18FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC.
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Clozapine filed by Teva Pharmaceuticals USA, Inc. The approval indicates an update to the Cl…
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine by Mylan Pharmaceuticals Inc.
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application from Aurobindo Pharma Limited for clozapine, allowing the generic product to be marketed.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism [Phase 4]
Phase 4 clinical trial update examining the impact of once-monthly aripiprazole on brain structure and metabolism in patients with schizophr…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment [Phase 1, Phase 2]
A clinical trial update comparing one-month versus three-month paliperidone palmitate treatment in schizophrenia, across Phase 1 and Phase 2…
-
FDA label_change · 2021-02-12FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals to update the product labeling, …
-
FDA approval · 2021-02-12FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
The FDA approved Janssen's supplemental application for risperidone, resulting in changes to its labeling/indications.
-
FDA approval · 2021-02-12FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2021-02-12FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
The FDA approved a supplemental application for INVEGA HAFYERA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.